Author

Alfonso Illiano

Institution: University of Naples Federico II

Observed institutions: University of Cagliari, University of Campania "Luigi Vanvitelli", Istituto Oncologico Veneto, Azienda Ospedaliera S.Giuseppe Moscati, Ospedale Monaldi, National Cancer Institute, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Canadian Cancer Trials Group, University of Naples Federico II

OpenAlex ID: A5103824318

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

2012 · Rafael Rosell, Enric Carcereny, et al. · The Lancet Oncology · 5,527

Gemcitabine Plus Vinorelbine Compared With Cisplatin Plus Vinorelbine or Cisplatin Plus Gemcitabine for Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group

2003 · Cesare Gridelli, Ciro Gallo, et al. · Journal of Clinical Oncology · 248

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials

2005 · Massimo Di Maio, Cesare Gridelli, et al. · The Lancet Oncology · 234

Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer

2019 · Lucio Crinò, Giuseppe Bronte, et al. · Lung Cancer · 153

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

2018 · Francesco Passiglia, Federico Cappuzzo, et al. · British Journal of Cancer · 82

Cisplatin Plus Gemcitabine or Vinorelbine for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The MILES-2P Studies

2007 · Cesare Gridelli, Paolo Maione, et al. · Journal of Clinical Oncology · 79

EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non–small cell lung carcinoma patients

2013 · Umberto Malapelle, Claudio Bellevicine, et al. · Cancer Cytopathology · 77

EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study

2011 · Umberto Malapelle, Nicla de Rosa, et al. · Journal of Clinical Pathology · 77

Phase I-II Study of Gemcitabine and Carboplatin in Stage IIIB-IV Non–Small-Cell Lung Cancer

1999 · Rosario Vincenzo Iaffaioli, Anna Tortoriello, et al. · Journal of Clinical Oncology · 76

Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program

2019 · Editta Baldini, Alice Lunghi, et al. · Lung Cancer · 43

EGFR mutations detection on liquid-based cytology: is microscopy still necessary?

2012 · Umberto Malapelle, Nicla de Rosa, et al. · Journal of Clinical Pathology · 36

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

2012 · Massimo Di Maio, Simona Signoriello, et al. · Lung Cancer · 22

Phase I–II study of gemcitabine and paclitaxel in pretreated patients with stage IIIB–IV non-small cell lung cancer

2000 · Rosario Vincenzo Iaffaioli, Anna Tortoriello, et al. · Lung Cancer · 13

Phase I study of vinorelbine and paclitaxel in small-cell lung cancer

1997 · Rosario Vincenzo Iaffaioli, Gaetano Facchini, et al. · Cancer Chemotherapy and Pharmacology · 8

Phase I/II study of gemcitabine and epirubicine in stage IIIB-IV non small cell lung cancer

2006 · Alfonso Illiano · Frontiers in bioscience · 1

P3.02c-092 Nivolumab in Multi-Treated Patients with Advanced Sq-NSCLC: Data from the Italian Cohort of Expanded Access Programme (EAP)

2017 · Marcello Tiseo, Lucio Crinò, et al. · Journal of Thoracic Oncology

Works count: 16

Citation count: 6,676

H-index: 13

I10-index: 13